Roche
Search results
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
ASRS 2024 Annual Meeting. At this year’s American Society of Retina Specialists (ASRS) annual meeting, we’re showcasing our latest research on treatment advancements for diabetic eye disease. Follow the official meeting hashtag, #ASRS2024, and read more below. Breakthrough science.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines.
Genentech | 751,651 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.
Genentech is committed to defeating cancer. Building upon our legacy as pioneers in oncology, we're boldly innovating beyond the science and envision a better future for every cancer patient, caregiver, and provider. We can't do it alone.
Roche acknowledged the strength of the Genentech name to scientists, doctors and patients, rebranding its own medicines “Genentech” in the U.S. In addition, Genentech had top scientists, a streamlined decision-making process, state-of-the-art research facilities, and a robust pipeline filled with new molecules.
ジェネンテック inc (Genentech inc.) は、アメリカ カリフォルニア州 サンフランシスコに本社を置くバイオベンチャー企業のパイオニアである。 バイオベンチャーとしては アムジェン に次ぐ世界二位の売上規模を誇り、日本最大の製薬会社である 武田 ...
WHY GENENTECH. We’re passionate about delivering on Our Promise to improve the lives of patients and create healthier communities for all. We foster a culture of inclusivity, integrity and creativity while boldly pursuing answers to the world’s most complex health challenges and transforming society.
